Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Assets (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Assets of $6.08 billion for the quarter ended Jun 30, 2026, up 0.1% from $6.07 billion a year earlier but down 4.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Assets (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories posted Assets of $6.18 billion, up 7.0% from the prior year.

  • Assets has increased for six consecutive years, with a five-year compound annual growth rate of 11.2% (years ended Mar 2021 to Mar 2026).
  • By year, Assets came in at $5.77 billion in the year ended Mar 31, 2025 (+24.1%), $4.65 billion in the year ended Mar 31, 2024 (+18.7%), $3.92 billion in the year ended Mar 31, 2023 (+1.5%) and $3.86 billion in the year ended Mar 31, 2022 (+6.3%).
  • Five-year quarterly Assets spans a low of $3.65 billion in the quarter ended Sep 30, 2022 and a high of $6.34 billion in the quarter ended Mar 31, 2026.
  • Year over year, Assets has now increased in each of the last 14 quarters, with growth averaging 17.2% over the last eight quarters.
  • The high point for year-over-year Assets in five years was the quarter ended Sep 30, 2024 (growth of 32.5%); the low point was the quarter ended Sep 30, 2022 (a decline of 2.9%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $6.34 billion (quarter ended Mar 31, 2026), $6.32 billion (quarter ended Dec 31, 2025) and $6.21 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 6.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.08 Bn
Mar 31, 2026 6.34 Bn
Dec 31, 2025 6.32 Bn
Sep 30, 2025 6.21 Bn
Jun 30, 2025 6.07 Bn
Mar 31, 2025 5.69 Bn
Dec 31, 2024 5.70 Bn
Sep 30, 2024 5.56 Bn
Jun 30, 2024 4.98 Bn
Mar 31, 2024 4.67 Bn
Dec 31, 2023 4.48 Bn
Sep 30, 2023 4.20 Bn
Jun 30, 2023 4.08 Bn
Mar 31, 2023 3.92 Bn
Dec 31, 2022 3.77 Bn
Sep 30, 2022 3.65 Bn
Jun 30, 2022 3.84 Bn
Mar 31, 2022 3.89 Bn
Dec 31, 2021 3.77 Bn
Sep 30, 2021 3.76 Bn
API Access

Dr Reddys Laboratories Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=RDY&period=max&api_key=YOUR_API_KEY